«It's the lower overall cost of therapy. (cnbc.com)
Some pharmaceutical companies appear to be «setting new, higher prices in lockstep with competitors — a strategy known as «shadow pricing,»» Cummings and Welch said, noting that the average annual cost of therapy had increased to more than $ 60,000 in 2015 from about $ 16,000 in 2004. (bloomberg.com)
The main sources of concern associated with growth hormone replacement in somatopause include, in no particular order, significant cost of therapy from $ 250 to $ 1500 per month (depending on dose and manufacturer), side effects of water retention resulting in joint pain and carpal tunnel syndrome, temporary reduction in insulin sensitivity, and theoretic risk of cancer. (holtorfmed.com)